Company / Current Liabilities
RECURSION PHARMACEUTICALS, INC. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$147.7M
FY2025
5-year range
$46.7M / $187.5M
FY2021-FY2025
Trend
-21.2%
vs FY2024
Sector context
#72 of 213
Health Care
What the data says
At $148M, RECURSION PHARMACEUTICALS, INC.'s current liabilities ranks #142 of 213 in the Health Care sector. Current Liabilities has fluctuated over the past 6 years, ranging from $23M in FY2020 to $187M in FY2024.
Based on SEC 10-K filings.
$148M in FY2025 with a 5-year CAGR of +44.9%.
Increased from $93M to $148M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +13.8%
- 5-Year CAGR
- +44.9%
- 10-Year CAGR
- -
Sector benchmark
#142 of 213 in Health CareTop 66% of 213This company $147.7M Sector average $1.6B
▼
-90.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +44.9%, indicating consistent growth.
- In FY2025, current liabilities decreased 21.2% year-over-year.
- Ranks #72 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $147.7M | -21.2% |
| FY2024 | $187.5M | +101.2% |
| FY2023 | $93.2M | -7.1% |
| FY2022 | $100.3M | +114.9% |
| FY2021 | $46.7M | +102.0% |
| FY2020 | $23.1M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026